These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 27668581)
1. Serum cholecystokinin concentrations in dogs with naturally acquired pituitary-dependent hyperadrenocorticism. Noh S; Kim HS; Chang J; Kang JH; Chang D; Yang MP Am J Vet Res; 2016 Oct; 77(10):1101-7. PubMed ID: 27668581 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of low- and high-dose trilostane treatment in dogs (< 5 kg) with pituitary-dependent hyperadrenocorticism. Cho KD; Kang JH; Chang D; Na KJ; Yang MP J Vet Intern Med; 2013; 27(1):91-8. PubMed ID: 23167780 [TBL] [Abstract][Full Text] [Related]
3. Clinical Relationship between Cholestatic Disease and Pituitary-Dependent Hyperadrenocorticism in Dogs: A Retrospective Case Series. Kim KH; Han SM; Jeon KO; Kim HT; Li Q; Ryu MO; Song WJ; Park SC; Youn HY J Vet Intern Med; 2017 Mar; 31(2):335-342. PubMed ID: 28064467 [TBL] [Abstract][Full Text] [Related]
4. Serum adipokine concentrations in dogs with naturally occurring pituitary-dependent hyperadrenocorticism. Cho KD; Paek J; Kang JH; Chang D; Na KJ; Yang MP J Vet Intern Med; 2014; 28(2):429-36. PubMed ID: 24372863 [TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of cortisol and cortisone in healthy dogs and dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Sieber-Ruckstuhl NS; Boretti FS; Wenger M; Maser-Gluth C; Reusch CE Vet Rec; 2008 Oct; 163(16):477-81. PubMed ID: 18931355 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of 2 trilostane protocols for the treatment of canine pituitary-dependent hyperadrenocorticism: twice daily versus once daily. Arenas C; Melián C; Pérez-Alenza MD J Vet Intern Med; 2013; 27(6):1478-85. PubMed ID: 24118316 [TBL] [Abstract][Full Text] [Related]
7. Cortisol, aldosterone, cortisol precursor, androgen and endogenous ACTH concentrations in dogs with pituitary-dependant hyperadrenocorticism treated with trilostane. Sieber-Ruckstuhl NS; Boretti FS; Wenger M; Maser-Gluth C; Reusch CE Domest Anim Endocrinol; 2006 Jul; 31(1):63-75. PubMed ID: 16233969 [TBL] [Abstract][Full Text] [Related]
8. Effect of trilostane on hormone and serum electrolyte concentrations in dogs with pituitary-dependent hyperadrenocorticism. Griebsch C; Lehnert C; Williams GJ; Failing K; Neiger R J Vet Intern Med; 2014; 28(1):160-5. PubMed ID: 24341822 [TBL] [Abstract][Full Text] [Related]
9. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Ruckstuhl NS; Nett CS; Reusch CE Am J Vet Res; 2002 Apr; 63(4):506-12. PubMed ID: 11939311 [TBL] [Abstract][Full Text] [Related]
10. Effect of trilostane on serum concentrations of aldosterone, cortisol, and potassium in dogs with pituitary-dependent hyperadrenocorticism. Wenger M; Sieber-Ruckstuhl NS; Müller C; Reusch CE Am J Vet Res; 2004 Sep; 65(9):1245-50. PubMed ID: 15478772 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Survival Times for Dogs with Pituitary-Dependent Hyperadrenocorticism in a Primary-Care Hospital: Treated with Trilostane versus Untreated. Nagata N; Kojima K; Yuki M J Vet Intern Med; 2017 Jan; 31(1):22-28. PubMed ID: 27906457 [TBL] [Abstract][Full Text] [Related]
12. Study of the effects of once daily doses of trilostane on cortisol concentrations and responsiveness to adrenocorticotrophic hormone in hyperadrenocorticoid dogs. Bell R; Neiger R; McGrotty Y; Ramsey IK Vet Rec; 2006 Aug; 159(9):277-81. PubMed ID: 16946310 [TBL] [Abstract][Full Text] [Related]
13. Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism. Braddock JA; Church DB; Robertson ID; Watson AD Aust Vet J; 2003 Oct; 81(10):600-7. PubMed ID: 15080470 [TBL] [Abstract][Full Text] [Related]
14. Laboratory assessment of trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism. Arenas Bermejo C; Pérez Alenza D; García San José P; Llauet L; Pérez-López L; Melián C; C Feldman E J Vet Intern Med; 2020 Jul; 34(4):1413-1422. PubMed ID: 32533623 [TBL] [Abstract][Full Text] [Related]
15. The effect of trilostane treatment on circulating thyroid hormone concentrations in dogs with pituitary-dependent hyperadrenocorticism. Kenefick SJ; Neiger R J Small Anim Pract; 2008 Mar; 49(3):139-43. PubMed ID: 18086154 [TBL] [Abstract][Full Text] [Related]
16. Adrenocorticotropic hormone levels in dogs with pituitary-dependent hyperadrenocorticism following trilostane therapy. Witt AL; Neiger R Vet Rec; 2004 Mar; 154(13):399-400. PubMed ID: 15083974 [No Abstract] [Full Text] [Related]
17. Evaluation of twice-daily, low-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism. Vaughan MA; Feldman EC; Hoar BR; Nelson RW J Am Vet Med Assoc; 2008 May; 232(9):1321-8. PubMed ID: 18447776 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the use of baseline cortisol concentration as a monitoring tool for dogs receiving trilostane as a treatment for hyperadrenocorticism. Cook AK; Bond KG J Am Vet Med Assoc; 2010 Oct; 237(7):801-5. PubMed ID: 20919845 [TBL] [Abstract][Full Text] [Related]
19. The effect of 1 year of trilostane treatment on peripheral lymphocyte subsets in dogs with pituitary-dependent hyperadrenocorticism. Oda H; Mori A; Shono S; Onozawa E; Sako T J Vet Med Sci; 2016 Jun; 78(5):851-4. PubMed ID: 26782012 [TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy of trilostane administered twice daily in dogs with pituitary-dependent hyperadrenocorticism. Alenza DP; Arenas C; Lopez ML; Melian C J Am Anim Hosp Assoc; 2006; 42(4):269-76. PubMed ID: 16822765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]